New FDA Supply Chain Program Aims To Prevent Device Shortages

The new program will be the focus of the agency’s June workshop

The US Food and Drug Administration is building a new Resilient Supply Chain Program, which aims to bolster the nation’s supply of essential medical devices and prevent future shortages.

COVID-19 Cargo
• Source: Alamy

More from Regulation

More from Policy & Regulation